Cargando…
Schisandrin B attenuates CCl(4)-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-β/Smad signaling pathways
Liver fibrosis is a major pathological feature of chronic liver diseases and there is no effective therapy program at present. Schisandrin B (Sch B) is the major bioactive ingredient of Schisandra chinensis, with antioxidative, anti-inflammatory, antitumor, and hepatoprotective properties. This stud...
Autores principales: | Chen, Qingshan, Zhang, Hai, Cao, Yan, Li, Ying, Sun, Sen, Zhang, Junping, Zhang, Guoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538685/ https://www.ncbi.nlm.nih.gov/pubmed/28794616 http://dx.doi.org/10.2147/DDDT.S137507 |
Ejemplares similares
-
Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPARγ
por: Chen, Qingshan, et al.
Publicado: (2021) -
Aspirin attenuates liver fibrosis by suppressing TGF-β1/Smad signaling
por: Sun, Yimin, et al.
Publicado: (2022) -
Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling
por: Song, Yu, et al.
Publicado: (2023) -
Acupuncture attenuates renal interstitial fibrosis via the TGF-β/Smad pathway
por: Zuo, Zheng, et al.
Publicado: (2019) -
The polysaccharides from Grifola frondosa attenuate CCl(4)-induced hepatic fibrosis in rats via the TGF-β/Smad signaling pathway
por: Li, Chao, et al.
Publicado: (2019)